Statesville Hma LLC
Statesville Hma LLC was paid $3.63M by Medicaid between Jan 2018 and Aug 2022, across 65 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
STATESVILLE, NC 28625
Next to other General Acute Care Hospital providers in North Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,650 | $584K | |
| 2019 | 25,399 | $625K | |
| 2020 | 18,204 | $422K | |
| 2021 | 36,838 | $1.18M | |
| 2022 | 20,435 | $816K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 21,979 | 18,660 | $1.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 7,583 | 6,418 | $505K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.4% | 5,794 | 4,623 | $268K |
| 41899 | Unlisted procedure, dentoalveolar structures | 7.0% | 245 | 205 | $254K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.4% | 8,752 | 7,102 | $195K |
| 87428 | 3.3% | 1,796 | 1,476 | $120K | |
| 87650 | 2.9% | 4,573 | 3,995 | $106K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.6% | 713 | 579 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 12,479 | 10,664 | $92K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 1,227 | 1,024 | $90K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 2,975 | 2,695 | $86K |
| 80053 | Comprehensive metabolic panel | 2.3% | 8,745 | 7,559 | $84K |
53 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.4% | 1,782 | $51K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 2,106 | $49K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 1,144 | $43K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,269 | $42K |
| 84703 | <1% | 4,437 | $36K | |
| 87400 | <1% | 2,870 | $34K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,178 | $34K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,151 | $24K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,124 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 209 | $19K |
| 81001 | <1% | 6,219 | $19K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 317 | $17K |
| 87070 | <1% | 1,624 | $17K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 224 | $15K |
| 83690 | <1% | 2,120 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 245 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,001 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 380 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 434 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 191 | $7K |
| 84484 | <1% | 860 | $6K | |
| 87420 | <1% | 345 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 64 | $5K |
| 99285 | Emergency room visit (most serious) | <1% | 61 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 32 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 547 | $4K |
| 80061 | Lipid panel | <1% | 218 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 210 | $3K |
| D1120 | Dental cleaning, child | <1% | 13 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 218 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 25 | $2K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 54 | $2K |
| 83735 | <1% | 275 | $2K | |
| 81003 | <1% | 745 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 319 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 41 | $954.10 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 41 | $954.10 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 27 | $828.86 |
| 82077 | <1% | 31 | $801.95 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 32 | $439.92 |
| D1206 | Topical application of fluoride varnish | <1% | 15 | $372.28 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 41 | $335.16 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 832 | $289.57 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 816 | $274.84 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 27 | $240.83 |
| J2704 | Injection, propofol, 10 mg | <1% | 316 | $215.05 |
| 86592 | <1% | 28 | $160.11 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 24 | $105.45 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 34 | $100.11 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 305 | $93.52 |
| 87210 | <1% | 13 | $43.80 | |
| 85378 | <1% | 13 | $35.56 | |
| 91301 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.